This isn't just a new drug
Forward-looking statements generally relate to future events or the Companys future financial or operating performance and may include, without limitation, statements regarding the anticipated launch, availability, distribution, commercialization and potential adoption of Forzet , the expected benefits of the product, the Companys plans to integrate Forzet into its pharmacy network and telehealth offerings, the development and expansion of the Companys direct-to-consumer initiatives, and the potential growth of the GLP-1 agonist market
Zepbound Zepbound is a tirzepatide injection approved for chronic weight management in eligible adults and should be used with a reduced-calorie diet and increased physical activity
HK Vanyai was supported by the Al & Val Rosenstrauss Fellowship from the Rebecca L
PMID: 28724644 Disclaimers FDA DSHEA Disclaimer This statement has not been evaluated by the Food and Drug Administration
Proven to lower A1C and help control blood sugar for a full 24 hours, its a choice for physicians and millions of patients worldwide